|
WO03006673A2
|
|
A nucleic acid encoding a human junctional adhesion protein (jam3)
|
|
AU9708401A
|
|
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
|
CA2361285A1
|
|
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
|
ZA200108771B
|
|
Propanoic acid derivatives that inhibit the binding of integrins to their receptors.
|
|
ZA200108775B
|
|
Propanoic acid derivatives that inhibit the binding of integrins to their receptors.
|
|
ZA200108777B
|
|
Carboxylic acid derivatives that inhibit the binding of integrins of their receptors.
|
|
US6723711B2
|
|
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
|
IL150311D0
|
|
Sulfonamides and derivatives thereof that modulate the activity of endothelin
|
|
WO0149289A1
|
|
Pharmaceutical and veterinary uses of endothelin antagonists
|
|
AU6660200A
|
|
Compounds that inhibit the binding of integrins to their receptors
|
|
AU6660100A
|
|
N,N-disubstituted amides that inhibit the binding of integrins to their receptors
|
|
EP1222205A1
|
|
POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR)
|
|
AU7067000A
|
|
A polynucleotide encoding a human junctional adhesion protein (jam-2)
|
|
CN1360498A
|
|
Carboxylic acid derivs. that inhibit binding of integrins to their receptors
|
|
AU5267900A
|
|
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
|
IL146312D0
|
|
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
|
US6376523B1
|
|
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
|
AU3580399A
|
|
Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
|
|
SK15602000A3
|
|
Compounds that inhibit the binding of integrins to their receptors
|
|
AU7684798A
|
|
Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
|
